BB BIOTECH AG

BION
Delayed Quote. Delayed  - 12/03 11:30:41 am
75.2CHF -2.15%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Other Biotechnology & Medical Research
BB Biotech is a portfolio company that specializes in investments in biotechnology companies. At the end of 2018, the stock portfolio, assessed at market value to be EUR3,064.2 million, breaks down by type of holding as follows:
- listed companies (99.9%): primarily Ionis Pharmaceuticals (rare diseases), Gilead Sciences (infectious viral diseases and flu), Celgene Corporation (cancer and inflammation of the immune system), Esperion Therapeutics (cardio-metabolic diseases), Vertex Pharmaceuticals (infectious diseases and diseases of the immune system) and Incyte (cancers, hematologic disorders and inflammatory diseases);
- other (0.1%).
Sales per Business
20192020
Investments in Biotechnology Industry240.87100%280.93100%
CHF in Million
Sales per region
20192020
Switzerland240.87100%280.93100%
CHF in Million
Managers
Name Title
Michael Hutter Head-Finance & Compliance
Erich Hunziker Chairman-Supervisory Board
Daniel Koller Head-Investment Management
Clive A. Meanwell Vice Chairman-Supervisory Board
Thomas von Planta Member-Supervisory Board
Mads Krogsgaard Thomsen Member-Supervisory Board
Susan Mary Galbraith Member-Supervisory Board
Silvia Siegfried-Schanz Investor Relations Contact
Felicia Flanigan Senior Biotech Analyst
Nathalie Isidora-Kwidam Portfolio Management
Shareholders
Name Equities %
Erich Hunziker 957,884 1.73%
UBS Asset Management Switzerland AG 925,765 1.67%
Credit Suisse Asset Management (Schweiz) AG 683,268 1.23%
BlackRock Asset Management Schweiz AG 651,220 1.18%
Zürcher Kantonalbank (Investment Management) 488,420 0.88%
UBP-Gestion Institutionnelle SA 296,066 0.53%
Arca Fondi SGR SpA 277,693 0.50%
Aberdeen Standard Capital Ltd. 224,091 0.40%
Vontobel Asset Management AG 205,506 0.37%
Symphonia SGR SpA 129,562 0.23%
Company contact information
BB Biotech AG
Schwertstrasse 6
Schaffhausen, Zurich 8200

Phone : +41.52.624.08.45
Web : http://www.bbbiotech.com
Sector Other Biotechnology & Medical Research
1st jan.Capi. (M$)
BB BIOTECH AG1.42%4 532
MODERNA, INC.193.60%124 359
LONZA GROUP AG25.98%58 058
IQVIA HOLDINGS INC.46.05%49 991
SEAGEN INC.-13.93%27 564
CELLTRION, INC.-41.36%24 298
ICON PUBLIC LIMITED COMPANY39.92%22 206
PHARMARON BEIJING CO., LTD.46.38%20 872
ALNYLAM PHARMACEUTICALS, INC.38.44%20 495
ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.59.99%19 746
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.43.03%18 035
BIO-TECHNE CORPORATION43.65%17 925
HANGZHOU TIGERMED CONSULTING CO., LTD-15.72%17 679
PPD, INC.37.87%16 603
INCYTE CORPORATION-23.40%14 530
QIAGEN N.V.2.57%12 305
NOVAVAX, INC.72.76%12 134
PRA HEALTH SCIENCES, INC.0.00%10 965
GENSCRIPT BIOTECH CORPORATION247.52%10 563
SYNEOS HEALTH, INC.41.63%10 082
BACHEM HOLDING AG58.03%9 754
Brand Portfolio
» More brands of BB Biotech AG